查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1673877

基因組工程市場：按技術、應用、最終用戶和地區

Genome Engineering Market, By Technology, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年全球基因組工程市場規模估計為 77億美元，預計到2032年將達到201.2億美元，2025-2032年的年複合成長率（CAGR）為 14.7%。

報告範圍 報告詳細資訊
基準年 2024 2025年市場規模 77億美元
歷史資料 2020-2024 預測期 2025-2032
預測期：2025-2032年年複合成長率 14.70％ 2032年金額預測 201.2億美元
圖表.2025年基因組工程市場佔有率（依地區）
基因組工程市場-IMG1

基因組工程，也稱為基因工程，是一組允許操縱或編輯生物體基因的技術。它包括改變生物體的基因組成，包括在物種內和跨物種引進基因，以產生改良或新的生物體。基因組工程利用 CRISPR/Cas9、TALEN、ZFN 和其他 DNA標靶化核酸酶等技術實現有針對性的基因組編輯和修改。研究人員成功地利用這些技術進行作物改良和各種生物體基因功能的實驗研究。由於各行各業擴大採用基因組技術，全球基因組工程市場預計將會成長。

市場動態

全球基因組工程市場的成長是由基因工程在生物技術、製藥和農業領域的日益廣泛的應用所推動的。 CRISPR 等基因組編輯工具為研究人員提供了無與倫比的精確度，可以輕鬆改變 DNA 序列和修改基因功能，促進成長機會。主要企業和政府對基因組工程研究的投資增加可能會推動市場成長。然而，與人類基因編輯的安全性和倫理相關的不確定性可能會對市場進入者造成挑戰。加大研發力度，開發更精確、更有效率的基因組工程工具，可望為市場成長提供新的機會。此外，環境修復和能源生產等新應用領域的開發也為不久的將來的市場成長帶來了巨大的潛力。

研究的主要特點

  • 本報告對全球基因組工程市場進行了詳細分析，並以2024年為基準年，給出了預測期（2025-2032年）的市場規模（十億美元）和年複合成長率（CAGR%）。
  • 強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
  • 提供對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 全球基因組工程市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行的分析。
  • 其中包括的主要公司有 Thermo Fisher Scientific Inc.、CRISPR Therapeutics AG、Intellia Therapeutics, Inc.、Editas Medicine, Inc.、Sangamo Therapeutics, Inc.、Bluebird Bio, Inc.、Cellectis SA、Merck KGaA、New England Biolabs、Aanific Technologies Inc. .
  • 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球基因組工程市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過全球基因組工程市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 製造商收益
  • 收購和合作場景
  • 產品發布/核准
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章 全球基因組工程市場-COVID-19 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

第5章 2020年至2032年全球基因體工程市場（依技術分類）（十億美元）

  • 介紹
  • CRISPR
  • TALEN
  • ZFN
  • 其他

第6章 2020年至2032年全球基因體工程市場（依應用分類）（十億美元）

  • 介紹
  • 細胞株工程
  • 基因工程

第7章 2020年至2032年全球基因體工程市場（以最終用戶分類）（十億美元）

  • 介紹
  • 生物科技和製藥公司
  • 研究所
  • 合約研究組織

第8章 2020年至2032年全球基因體工程市場（依地區分類）（十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • CRISPR Therapeutics AG
    • Intellia Therapeutics, Inc.
    • Editas Medicine, Inc.
    • Sangamo Therapeutics, Inc.
    • Bluebird Bio, Inc.
    • Cellectis SA
    • Merck KGaA
    • New England Biolabs
    • Agilent Technologies, Inc.
    • Genscript
    • Synbio Technologies
    • Creative Biogene
    • Eurofins Scientific
    • Regeneron Pharmaceuticals Inc.

第10章 分析師建議

  • 興衰
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1262

Global Genome Engineering Market is estimated to be valued at USD 7.70 Bn in 2025 and is expected to reach USD 20.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 7.70 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.70% 2032 Value Projection: USD 20.12 Bn
Figure. Genome Engineering Market Share (%), By Region 2025
Genome Engineering Market - IMG1

Genome engineering, also known as genetic engineering, is a set of technologies that enable genetic manipulation and editing of an organism's genes. It involves the alteration of an organism's genetic makeup, including the transfer of genes within and across species boundaries to produce improved or novel organisms. Genome engineering utilizes technologies such as CRISPR/Cas9, TALENs, ZFNs and other DNA targeting nucleases to enable targeted genome editing and modification. Researchers have successfully utilized these technologies for crop improvement and experimental investigation of gene function in various organisms. Global genome engineering market is expected to witness growth due to increasing adoption of genome technologies in various industries.

Market Dynamics:

Global genome engineering market growth is driven by rising application of genetic engineering in areas of biotechnology, pharmaceuticals and agriculture. Genome editing tools such as CRISPR have provided researchers unparalleled precision to easily alter DNA sequences and modify gene function, fueling growth opportunities. Growing investment by key players and governments in genome engineering-based research can drive the market growth. However, uncertainties related to safety and ethics of human gene editing can pose a challenge to market players. Increasing R&D for developing more accurate and efficient genome engineering tools is expected to offer new opportunities for the market growth. Exploration of novel applications areas such as environmental remediation and energy production also hold immense potential for market growth in the near future.

Key Features of the Study:

  • This report provides an in-depth analysis of the global genome engineering market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global genome engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Cellectis S.A., Merck KGaA, New England Biolabs, Agilent Technologies, Inc., Genscript, Synbio Technologies, Creative Biogene, Eurofins Scientific, Regeneron Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global genome engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genome engineering market.

Detailed Segmentation-

  • By Technology:
    • CRISPR
    • TALEN
    • ZFN
    • Others
  • By Application:
    • Cell Line Engineering
    • Genetic Engineering
  • By End User:
    • Biotechnology & Pharmaceutical Companies
    • Research Institutes
    • Contract Research Organizations
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • CRISPR Therapeutics AG
    • Intellia Therapeutics, Inc.
    • Editas Medicine, Inc.
    • Sangamo Therapeutics, Inc.
    • Bluebird Bio, Inc.
    • Cellectis S.A.
    • Merck KGaA
    • New England Biolabs
    • Agilent Technologies, Inc.
    • Genscript
    • Synbio Technologies
    • Creative Biogene
    • Eurofins Scientific
    • Regeneron Pharmaceuticals Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Genome Engineering Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Genome Engineering Market, By Technology, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • CRISPR
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • TALEN
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • ZFN
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Genome Engineering Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Cell Line Engineering
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genetic Engineering
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Genome Engineering Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Biotechnology & Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Genome Engineering Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CRISPR Therapeutics AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Intellia Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Editas Medicine, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sangamo Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bluebird Bio, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cellectis S.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • New England Biolabs
    • Agilent Technologies, Inc.
    • Genscript
    • Synbio Technologies
    • Creative Biogene
    • Eurofins Scientific
    • Regeneron Pharmaceuticals Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact

"